|
PYROXD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21656026866413E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55049972860866E-10 |
| Normal-vs-Stage2 |
1.75489999998391E-06 |
| Normal-vs-Stage3 |
8.62159998948897E-09 |
| Normal-vs-Stage4 |
7.60610000000161E-05 |
| Stage1-vs-Stage2 |
6.155400E-01 |
| Stage1-vs-Stage3 |
5.521800E-01 |
| Stage1-vs-Stage4 |
9.565800E-01 |
| Stage2-vs-Stage3 |
9.966800E-01 |
| Stage2-vs-Stage4 |
7.929400E-01 |
| Stage3-vs-Stage4 |
7.361800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.70996550252767E-12 |
| Normal-vs-AfricanAmerican |
2.02130000004352E-06 |
| Normal-vs-Asian |
2.22089999999397E-05 |
| Caucasian-vs-AfricanAmerican |
3.905600E-02 |
| Caucasian-vs-Asian |
3.457000E-01 |
| AfricanAmerican-vs-Asian |
1.547040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89603888145484E-12 |
| Normal-vs-Female |
1.59099999841317E-08 |
| Male-vs-Female |
6.788100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.28529999976479E-07 |
| Normal-vs-Extreme_Weight |
9.35340693786202E-12 |
| Normal-vs-Obese |
4.05730005148541E-10 |
| Normal-vs-Extreme_Obese |
1.18979999996771E-06 |
| Normal_Weight-vs-Extreme_Weight |
3.909200E-01 |
| Normal_Weight-vs-Obese |
5.317400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.562400E-01 |
| Extreme_Weight-vs-Obese |
8.405000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.929400E-01 |
| Obese-vs-Extreme_Obese |
5.430600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.59050000339656E-08 |
| Normal-vs-Age(41-60Yrs) |
1.72230008033125E-10 |
| Normal-vs-Age(61-80Yrs) |
3.32299743277531E-11 |
| Normal-vs-Age(81-100Yrs) |
1.807800000031E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.816300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.975200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.123600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.352210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.221400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.273400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.90158999657797E-12 |
| Normal-VS-Type2 PRCC |
4.82249995492623E-09 |
| Normal-VS-KIRP CIMP |
5.34409999586316E-08 |
| Normal-VS-Unclassified PRCC |
5.33099999699971E-08 |
| Type1 PRCC-VS-Type2 PRCC |
9.548400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.774300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.110400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.249900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.832200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.997770E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.41920039556476E-10 |
| Normal-vs-N1 |
1.16560000540389E-08 |
| Normal-vs-N2 |
1.099970E-02 |
| N0-vs-N1 |
4.135000E-01 |
| N0-vs-N2 |
6.500800E-01 |
| N1-vs-N2 |
9.157600E-01 |
|
|
